Macquarie raises Neuren Pharmaceuticals price target to A$24.50
Macquarie raised Neuren Pharmaceuticals’ price target by 6.5% to A$24.50 per share.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.